Yetişir, A. Et Al. 2024. Evaluation of inflammatory biomarkers and the ratio of hemoglobin-red cell distribution width in patients with rheumatoid arthritis treated with tumor necrosis factor-alpha inhibitors. Clinical Rheumatology .

Yetişir, A., SARIYILDIZ, A., TÜRK, İ., & COŞKUN BENLİDAYI, İ., (2024). Evaluation of inflammatory biomarkers and the ratio of hemoglobin-red cell distribution width in patients with rheumatoid arthritis treated with tumor necrosis factor-alpha inhibitors. Clinical Rheumatology .

Yetişir, Ayşegül Et Al. "Evaluation of inflammatory biomarkers and the ratio of hemoglobin-red cell distribution width in patients with rheumatoid arthritis treated with tumor necrosis factor-alpha inhibitors," Clinical Rheumatology , 2024

Yetişir, Ayşegül Et Al. "Evaluation of inflammatory biomarkers and the ratio of hemoglobin-red cell distribution width in patients with rheumatoid arthritis treated with tumor necrosis factor-alpha inhibitors." Clinical Rheumatology , 2024

Yetişir, A. Et Al. (2024) . "Evaluation of inflammatory biomarkers and the ratio of hemoglobin-red cell distribution width in patients with rheumatoid arthritis treated with tumor necrosis factor-alpha inhibitors." Clinical Rheumatology .

@article{article, author={Ayşegül Yetişir Et Al. }, title={Evaluation of inflammatory biomarkers and the ratio of hemoglobin-red cell distribution width in patients with rheumatoid arthritis treated with tumor necrosis factor-alpha inhibitors}, journal={Clinical Rheumatology}, year=2024}